Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BOVINE-DERIVED MATERIAL USE IN FDA-REGULATED PRODUCTS

This article was originally published in The Rose Sheet

Executive Summary

BOVINE-DERIVED MATERIAL USE IN FDA-REGULATED PRODUCTS intended for administration to humans should be limited to products from cattle which have not "resided in or originated from countries where bovine spongiform encephalopathy (BSE) has been diagnosed," FDA Deputy Commissioner for Operations Jane Henney said in a Dec. 17 letter to manufacturers.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

RS000005

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel